<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>propionate decreases colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>propionate</strong>
  <span class="pred">&mdash;decreases&rarr;</span>
  <strong>colorectal cancer</strong>
</div>
<div class="entity-id">HMDB:HMDB0000237 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 3 papers</span>
  <span>Score: 19.87<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">EVIDENCE CHAIN &middot; 3 sources</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.18632/oncotarget.8762">10.18632/oncotarget.8762</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.3760/cma.j.issn.0253-9624.2016.09.008">10.3760/cma.j.issn.0253-9624.2016.09.008</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#d62728" title="AI Generated"></span><span>AI Generated</span><a href="https://doi.org/10.1097/MD.0000000000044102">10.1097/MD.0000000000044102</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 24 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>10</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Plasma metabolite panel (29 metabolites) — distinguishes → Colorectal Cancer (Stage 0/I/II)</span><a href="../claim/95c047c5809cf90e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Multiple logistic regression metabolite model — predicts → Colorectal Cancer (Stage 0/I/II)</span><a href="../claim/efcf3b9a8d3c16a3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Multiple logistic regression metabolite model — distinguishes → Colorectal Cancer Stage 0</span><a href="../claim/ebb74bfb7b04f8d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Serum metabolome panel — predicts → Pathological complete response to neoadjuvant chemoradiation in rectal cancer</span><a href="../claim/8f1cb6c1972c454c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Taurine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><a href="../claim/b8f182218b41caec.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Phenylalanine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><a href="../claim/f44c784f3ebfd339.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Pre-treatment serum metabolome — predicts → Tumor regression grade in locally advanced rectal cancer</span><a href="../claim/5c859bcad8ee82fe.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Taurine — correlates_with → Pathological complete response to chemoradiation in rectal cancer</span><a href="../claim/3d0a94a0b2d89900.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fecal acetate — correlates_with → myo-inositol</span><a href="../claim/ae91c02d8932adb3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Colorectal cancer — causes → death</span><a href="../claim/2210739709380dcd.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:60px"></span><span>6</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">acetate — distinguishes → colorectal cancer</span><a href="../claim/a5c8acd30fde2f75.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">succinate — increases → colorectal cancer</span><a href="../claim/ce532437c6d43088.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">alanine — increases → colorectal cancer</span><a href="../claim/6681e0fa7154e760.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">glutamate — increases → colorectal cancer</span><a href="../claim/d2f2d64e2fd73655.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lactate — increases → colorectal cancer</span><a href="../claim/7b11f67bd2db6cda.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Serum purine metabolites (hypoxanthine, xanthine, inosine) — is_biomarker_for → Locally advanced rectal cancer pathological complete response</span><a href="../claim/3277beb972cb2688.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:80px"></span><span>8</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">butyrate — decreases → colorectal cancer</span><a href="../claim/7ec6028950ee0b80.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Glycerophosphocholine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><a href="../claim/d3bb9891d357bc29.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Hypoxanthine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><a href="../claim/29911b76436518a8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Xanthine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><a href="../claim/3f23f075b8470c9b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Inosine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><a href="../claim/06310cfe572ab0ec.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Lysophosphatidylcholine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><a href="../claim/61ac2deeff608e5d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Glycerophosphocholine — increases → Pathological complete response to chemoradiation in rectal cancer</span><a href="../claim/e1efebf2b733d62b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fecal acetate — correlates_with → glucose</span><a href="../claim/6000b56d3b723162.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>6161e4f8d9f6878a</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000237">HMDB:HMDB0000237</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
